SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Juno Therapeutics Inc. (JUNO) -- Ignore unavailable to you. Want to Upgrade?


To: Biotech Jim who wrote (25)7/2/2015 6:23:36 PM
From: scaram(o)uche  Respond to of 84
 
I like the deal, Jim. Believe that none of CD19 et al. will determine the eventual winners, and that resources need to flood both scale-up demands and a variety of projects which will emerge from academic labs.

Juno wins, regardless of what Novartis, Kite et al. do in the next two years.

Celgene? Bold. Gets to take 30% of juno, what other company can say that? Heh.

New, from a juno scientific founder's lab......

nature.com

Happy 4th!